XML 19 R5.htm IDEA: XBRL DOCUMENT v3.26.3
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Sep. 30, 2026
Dec. 31, 2025
Cash and cash equivalents    
Cash and due from banks $ 3,669 $ 3,559
Interest-bearing deposits in other banks 39,294 43,491
Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $72; 2025, $84) 240 742
Total cash and cash equivalents (includes restricted cash: 2026, $166; 2025, $169) 43,203 47,792
Investment securities 5,117 1,043
Premises and equipment, less accumulated depreciation and amortization: 2026, $13,266; 2025, $12,039 8,122 6,118
Other assets, less reserves for credit losses: 2026, $123; 2025, $86 26,649 24,263
Total assets 310,275 300,052
Liabilities    
Customer deposits 155,019 152,488
Accounts payable 15,184 14,700
Short-term borrowings 1,415 1,371
Long-term debt (includes debt issued by consolidated variable interest entities: 2026, $12,177; 2025, $13,022) 58,538 56,387
Other liabilities 44,322 41,632
Total liabilities 274,478 266,578
Contingencies (Note 7)
Shareholders’ Equity    
Preferred shares, $1.662/3 par value, authorized 20 million shares; issued and outstanding 1,600 shares as of September 30, 2026 and December 31, 2025 0 0
Common shares, $0.20 par value, authorized 3.6 billion shares; issued and outstanding 671 million shares as of September 30, 2026 and 686 million shares as of December 31, 2025 134 138
Additional paid-in capital 11,168 11,126
Retained earnings 27,888 25,487
Accumulated other comprehensive income (loss) (3,393) (3,277)
Total shareholders’ equity 35,797 33,474
Total liabilities and shareholders’ equity 310,275 300,052
Card Balances    
Cash and cash equivalents    
Financing receivables, net 215,440 207,774
Financing receivables held for sale 0 2,457
Other Loans    
Cash and cash equivalents    
Financing receivables, net $ 11,744 $ 10,605